$ USD
¥ 人民币
$ USD
€ 欧元
English
简体中文
English
繁体中文
Sign In / Sign up
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Menu
Home page
News
Tumor Information
Tumor Information
Tumor medication
Tumor medication
Drug data
Drug data
Tumor medication
Oncology
renal cell carcinoma
cell tumor
solid tumors
IDH1 mutation
non-small cell lung cancer
neurofibromatosis
liposarcoma
neurofibromatosis
Cachexia
bladder cancer
Common Medications
Common medications
Hematology
Hepatobiliary
chronic disease
Endocrinology
Rare disease drugs
Other medications
insomnia
depression
chronic cough
kidney transplant
Drug Classification
Brand Medicine Search
Brand Medicine Search
日本日医工株式会社
日本盐野义制药
日本杏林制药株式会社
日本株式会社
老挝卢修斯
hormone receptor positive
constipate
heart disease
constipate
depression
日本株式会社
日本田边三菱
英国FuturaMedical制药
日本盐野义制药
日本杏林制药株式会社
Medical Q&A
Medical Q&A
About Us
About Us
Home
News
News
Medical Halo Global Pharmaceutical News_Targeted Drugs_New Anti-Cancer Drugs_Overseas Medical Information_【Medical Halo Global Pharmaceutical】
已上市的抗癌药曲美替尼价格,2021年多少钱
2025-10-19 11:44:20
Check Details
达拉非尼联合曲美替尼治疗晚期黑色素瘤,可以治好吗?
2025-10-19 11:44:20
Check Details
纳武单抗2021年进入医保了吗?纳武单抗用一个疗程多少钱?
2025-10-19 11:44:20
Check Details
纳武单抗每月花费多少钱?纳武单抗2021年医保能报销吗?
2025-10-19 11:44:20
Check Details
威罗菲尼一个月多少钱?威罗菲尼价格
2025-10-19 11:44:20
Check Details
威罗菲尼纳入医保了吗?威罗菲尼2021最新价格
2025-10-19 11:44:20
Check Details
靶向药威罗菲尼说明书,威罗菲尼在哪有卖的?
2025-10-19 11:44:20
Check Details
贝美替尼3月1日起最新价格多少?贝美替尼多少钱
2025-10-19 11:44:20
Check Details
恩考芬尼和贝美替尼联合治疗黑色素瘤取得“空前优势”
2025-10-19 11:44:20
Check Details
威罗菲尼国内上市了吗?威罗菲尼一个疗程多少天?
2025-10-19 11:44:20
Check Details
别担心,黑色素瘤患者需要贝美替尼,它来了
2025-10-19 11:44:20
Check Details
黑色素瘤治疗新药恩考芬尼(康奈非尼)价格多少钱
2025-10-19 11:44:20
Check Details
1
2
...
6740
6741
6742
6743
6744
6745
6746
...
10233
10234
Category
Oncology
Hepatobiliary
dermatology
Endocrinology
Hematology
Andrology
Gynecology
Nephrology
Urology
Department of Infectious Diseases
Gastroenterology
Respiratory department
Neurology
Cardiology and Brain Department
ophthalmology
Psychiatry
Immunology Department
orthopedics
Burn Department
相关知识
1
Post-Enzalutamide mCRPC: HRR/PARP, PSMA Radioligand, and Chemotherapy Sequencing
2
Ceritinib for ALK-Positive NSCLC: Indication, Dosing, and Safety Management
3
Acalabrutinib in CLL/SLL Survival Expectation: ELEVATE-TN and ASCEND Long-Term PFS, OS
4
Bosutinib for CML: Time to Response, BCR-ABL Monitoring, and Molecular Remission
5
Bedaquiline for Drug-Resistant TB: 24-Week Regimen, Combination Duration, and When to Stop or Extend
6
Acalabrutinib Dosing and Combination Regimens: CLL/SLL, MCL, Safety Adjustments
7
Enzalutamide for Prostate Cancer: Managing Fatigue, Dizziness, Hypertension, and Serious Neurocardiovascular Risks
8
Bosutinib for Ph+ CML: Indications, Dosing Adjustments, and Hepatic/Renal Safety
9
Tamoxifen Long-Term Safety: Vigilance for Thrombosis and Endometrial Risks
10
Acoramidis for ATTR-CM: Disease Progression Is Not Equivalent to Drug Resistance
11
Lorlatinib Contraindications and Safety Warnings: Six Key Risks to Monitor
12
AZA+VEN+IVO Triplet Therapy for Newly Diagnosed IDH1 AML: High Response Rates and Durable Efficacy